Downing Street is quietly celebrating a rare win. The UK-led Ebola vaccine programme is producing results. Recovery patients are emerging from treatment centres. They are walking out. Families are embracing them. This is the kind of imagery Number 10 has been craving.
Let's be clear. The outbreak is not over. The death toll is still climbing. But the vaccine, developed by a consortium including Oxford University and funded by British aid, is showing efficacy. The data is preliminary. But it is promising.
Whitehall sources tell me the mood in the Cabinet Office is cautiously optimistic. 'We have been taking a beating on aid spending,' one senior official said. 'This is a reminder of why we do it.' The reference is to the recent cuts to the overseas aid budget. The decision to slash spending from 0.7% to 0.5% of GDP has been deeply unpopular with the international development community. This vaccine programme is a rare piece of good news for the government's aid narrative.
But let's not get carried away. The politics are tricky. The vaccine is not a silver bullet. Distribution is a nightmare. Local infrastructure is shattered. Healthcare workers are being targeted. The UK's role is significant but not solitary. There are other players: the US, the EU, the WHO. And the usual tensions are present. Leaks from the WHO suggest frustration with the UK's bilateral approach. 'They want to go it alone,' a Geneva source grumbled. 'This is not a time for national flags.'
Back in Westminster, the Labour frontbench is watching closely. They have already accused the government of 'aiding and abetting' the outbreak by cutting the budget. The government's defence: we are still one of the largest donors. But the optics are difficult. A photo of a recovered patient hugging a nurse in a UK-funded clinic is worth a thousand press releases.
The bigger picture: this is a test case for 'Global Britain'. The phrase has been mocked. But if the vaccine works, if the UK can claim a share of the credit, it could shift the narrative. The Foreign Office is already drafting talking points. Expect to hear about 'British science', 'British values', and 'British leadership' in the coming days.
For now, the focus is on the human stories. The recovery patients. The families. The healthcare workers. They are the real story. The politics will follow. It always does.
